— Know what they know.
Not Investment Advice

600216.SS SHH

Zhejiang Medicine Co., Ltd.
1W: -2.3% 1M: -3.9% 3M: +6.2% YTD: -23.0% 1Y: -20.1% 3Y: +16.9% 5Y: -8.2%
¥12.43 ($1.85)
+0.25 (+2.05%)
 
SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 33 · ¥12.0B mcap · 569M float · 3.89% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥12.0B ($1.8B)
52W Range10.94-18.58
Volume10,204,470
Avg Volume22,130,977
Beta0.33
Dividend¥0.28
Analyst Ratings
No analyst coverage
Company Info
CEOHongwei Wang
Employees5,417
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1999-10-21
Websitezmc.top
168 Zhiyuan Middle Avenue
Shaoxing, ZH 312366
CN
86 575 8521 1969
About Zhejiang Medicine Co., Ltd.

Zhejiang Medicine Co., Ltd. is a Chinese enterprise specializing in the manufacturing and distribution of both nutritional supplements and pharmaceutical goods. Its life nutrition portfolio encompasses a wide array of offerings, such as synthetic and natural vitamin E, vitamin A, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, and lycopene, alongside various other vitamin compounds. Beyond nutrition, the company is a significant supplier in the pharmaceutical sector. This includes the production of active pharmaceutical ingredients and raw materials like specialized antibiotics for drug-resistant strains, anti-malarial compounds, and quinolone derivatives. Furthermore, it develops and markets finished pharmaceutical products, notably sugar-based medications and hormonal preparations. Established in 1997, Zhejiang Medicine Co., Ltd. maintains its headquarters in Shaoxing, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms